VM

Vijay Malshi Savla

Director Alternate Director DIN 02626796
DIN 02626796 First appointment Mar 2012 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijay Malshi Savla

Data last updated:

Vijay Malshi Savla was an Alternate Director at Zydus Takeda Healthcare Private Limited (2012–2015) and Director at Xema Software Services Private Limited (from 2012). The companies operate in Pharma.

DIN 02626796
Primary Designation Alternate Director
Industry Pharma
First Appointment 13 Mar 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alternate Director13 Mar 20121999₹362 Cr (FY 2025)Active
Director18 May 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Xema Software Services Private Limited
Zydus Takeda Healthcare Private Limited
Premium access

Shareholding and investment profile for Vijay Malshi Savla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Malshi Savla

Vijay Malshi Savla was first appointed on 13 Mar 2012 as Alternate Director at Zydus Takeda Healthcare Private Limited.

Vijay Malshi Savla held 2 earlier board appointments: Zydus Takeda Healthcare Private Limited (Alternate Director, 13 Mar 2012 to 13 Mar 2015); Xema Software Services Private Limited (Director, from 18 May 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available